| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.784 | 16.872 | 27.848 | 26.830 | 32.695 | 39.260 | 118.469 | 133.650 | 122.057 |
| Total Income - EUR | - | 7.784 | 16.872 | 27.871 | 28.964 | 32.697 | 39.367 | 118.886 | 133.693 | 122.068 |
| Total Expenses - EUR | - | 5.192 | 12.478 | 23.542 | 23.704 | 17.912 | 17.239 | 49.680 | 118.260 | 90.528 |
| Gross Profit/Loss - EUR | - | 2.592 | 4.394 | 4.329 | 5.260 | 14.785 | 22.129 | 69.205 | 15.433 | 31.541 |
| Net Profit/Loss - EUR | - | 2.436 | 4.225 | 4.050 | 4.971 | 14.463 | 21.782 | 68.040 | 14.096 | 27.020 |
| Employees | - | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Euromed Life Diagnostic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 3.053 | 2.696 | 9.238 | 6.993 | 9.220 | 12.409 | 10.609 |
| Current Assets | - | 4.995 | 7.805 | 8.829 | 19.525 | 23.944 | 45.615 | 102.058 | 115.263 | 153.208 |
| Inventories | - | 80 | 79 | 77 | 76 | 0 | 330 | 0 | 658 | 926 |
| Receivables | - | 0 | 6.711 | 3.889 | 8.059 | 2.414 | 31.144 | 44.096 | 80.172 | 145.973 |
| Cash | - | 4.915 | 1.015 | 4.862 | 11.389 | 21.529 | 14.140 | 57.962 | 34.433 | 6.309 |
| Shareholders Funds | - | 2.155 | 6.344 | 10.278 | 15.071 | 29.248 | 50.381 | 68.113 | 15.681 | 62.693 |
| Social Capital | - | 45 | 44 | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 2.840 | 1.461 | 1.604 | 7.149 | 3.934 | 2.226 | 43.165 | 111.991 | 101.124 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Euromed Life Diagnostic Srl